In that analysis, Geyer et al found that the protease inhibitors SERPINA3, ITIH3, and ITIH4 were increased in plasma abundance in COVID-19 patients, when compared with controls, whereas the HRG and fibronectin (FN1) were decreased. Here, ITIH3 is linked to COVID-19.